Focus: Liberate Medical develops respiratory electrical muscle stimulators, a niche medical device platform targeting artificial respiration and chronic respiratory diseases. The company operates as a pre-revenue biotech focused on functional electrical stimulation (FES) technology.
Profile data last refreshed 4h ago · AI intelligence enriched 2mo ago
Growing — net +12 jobs in 30d
42 jobs added vs 30 removed. Steady team buildout.
Liberate Medical is a pre-commercial, capital-constrained respiratory device biotech best suited for entrepreneurs or specialists willing to accept significant financial and execution risk in exchange for early equity upside and technical autonomy.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Liberate Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Liberate Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles